Home
VTRS
VTRS News

Latest Viatris Inc. (VTRS) News on December 18, 2024

Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology

PR Newswire

11 hours ago

Viatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet Rheumatology

MT Newswires

12 days ago

Piper Sandler Adjusts Price Target on Viatris to $14 From $13, Keeps Neutral Rating

MT Newswires

a month ago

Viatris Fined $1.9 Million Over Alleged Violation of Antitrust Restrictions

Viatris fined in Morocco over merger notification, sources say

Reuters

a month ago

Viatris fined in Morocco over merger notification, sources say

Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y

Zacks

a month ago

Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y

ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for $145m

Pharmaceutical Technology

a month ago

ALK snags EU and Canada rights to anaphylaxis nasal spray Neffy for $145m

GuruFocus.com

a month ago

Viatris Inc (VTRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ...

S&P 500 Gains and Losses Today: Index Ticks Higher as Fed Trims Benchmark Rate

Investopedia

a month ago

S&P 500 Gains and Losses Today: Index Ticks Higher as Fed Trims Benchmark Rate

Morningstar Research

a month ago

Analyst Report: Viatris Inc.

Viatris Beats on Q3 Earnings and Revenues, Lowers Profit Guidance

Zacks

a month ago

Viatris Beats on Q3 Earnings and Revenues, Lowers Profit Guidance

Viatris (VTRS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

a month ago

Viatris (VTRS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates

Zacks

a month ago

Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates

MT Newswires

a month ago

Viatris' Q3 Earnings, Revenue Decline; 2024 Adjusted EPS Guidance Lowered

Associated Press Finance

a month ago

Viatris: Q3 Earnings Snapshot

Viatris Reports Third Quarter Financial Results for 2024

PR Newswire

a month ago

Viatris Reports Third Quarter Financial Results for 2024

What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?

Zacks

a month ago

What's in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?

Viatris Announces Third Quarter 2024 Dividend

PR Newswire

a month ago

Viatris Announces Third Quarter 2024 Dividend

Viatris to Report Q3 Earnings: What's in the Cards?

Zacks

a month ago

Viatris to Report Q3 Earnings: What's in the Cards?

Unveiling Viatris (VTRS) Q3 Outlook: Wall Street Estimates for Key Metrics

Zacks

a month ago

Unveiling Viatris (VTRS) Q3 Outlook: Wall Street Estimates for Key Metrics

Viatris Named to Forbes' World's Top Companies for Women 2024 List

PR Newswire

2 months ago

Viatris Named to Forbes' World's Top Companies for Women 2024 List

Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference

PR Newswire

2 months ago

Viatris to Participate in the UBS Global Healthcare Conference and Jefferies London Healthcare Conference

Lexicon sells Viatris rights to cardio drug outside of the U.S. and Europe

BioPharma Dive

2 months ago

Lexicon sells Viatris rights to cardio drug outside of the U.S. and Europe

Lexicon partners Viatris for global expansion of sotagliflozin

Pharmaceutical Technology

2 months ago

Lexicon partners Viatris for global expansion of sotagliflozin

MT Newswires

2 months ago

Lexicon Pharmaceuticals to Get $25 Million From Viatris in Global Sotagliflozin Licensing Deal

Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe

GlobeNewswire

2 months ago

Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe

Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe

PR Newswire

2 months ago

Viatris Announces Exclusive Licensing Agreement with Lexicon Pharmaceuticals for Sotagliflozin in all Markets Outside of the U.S. and Europe

Strength Seen in Cencora (COR): Can Its 3.7% Jump Turn into More Strength?

Zacks

2 months ago

Strength Seen in Cencora (COR): Can Its 3.7% Jump Turn into More Strength?

GuruFocus.com

2 months ago

Viatris Settles Lawsuit, Avoids Antitrust Charges, and Advances Effexor Study

Viatris Inc. (VTRS): David Einhorn’s Top Stock Pick

Insider Monkey

2 months ago

Viatris Inc. (VTRS): David Einhorn’s Top Stock Pick

Viatris Inc. (VTRS): A Strategic Shift in Healthcare Investments

Insider Monkey

2 months ago

Viatris Inc. (VTRS): A Strategic Shift in Healthcare Investments

Viatris 2023 Sustainability Report: Reducing Packaging Material

ACCESSWIRE

2 months ago

Viatris 2023 Sustainability Report: Reducing Packaging Material

GuruFocus.com

2 months ago

Viatris Inc (VTRS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations

MT Newswires

2 months ago

Viatris Says EFFEXOR Met Primary Endpoint of Reducing Anxiety Symptoms in Phase 3 Trial

Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)

PR Newswire

2 months ago

Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD)

Is Viatris Inc. (NASDAQ:VTRS) The Best NASDAQ Stock Under $20?

Insider Monkey

2 months ago

Is Viatris Inc. (NASDAQ:VTRS) The Best NASDAQ Stock Under $20?

Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row

PR Newswire

2 months ago

Viatris Named to Forbes' Annual List of the World's Best Employers for the Fourth Year in a Row

Viatris 2023 Sustainability Report: Expanding Contractor Training

ACCESSWIRE

2 months ago

Viatris 2023 Sustainability Report: Expanding Contractor Training

Is Viatris Inc. (VTRS) the Best Stock Under $15 To Buy Now?

Insider Monkey

3 months ago

Is Viatris Inc. (VTRS) the Best Stock Under $15 To Buy Now?

Viatris launches (Pr)Viagra® ODF in Canada: a new oral dissolving film form of the erectile dysfunction treatment

CNW Group

3 months ago

Viatris launches (Pr)Viagra® ODF in Canada: a new oral dissolving film form of the erectile dysfunction treatment

In Europe, Packaging Site Takes Flight as a Bird-Friendly Workplace

ACCESSWIRE

3 months ago

In Europe, Packaging Site Takes Flight as a Bird-Friendly Workplace

Viatris 2023 Sustainability Report: Health and Safety in the Workplace

ACCESSWIRE

3 months ago

Viatris 2023 Sustainability Report: Health and Safety in the Workplace

MT Newswires

3 months ago

Viatris Prices Cash Tender Offer for Senior Notes

Viatris Announces the Pricing Terms of Maximum Tender Offer

PR Newswire

3 months ago

Viatris Announces the Pricing Terms of Maximum Tender Offer

MT Newswires

3 months ago

Viatris Unit Utah Acquisition Sub Increases Maximum Amount of Cash Tender Offer to $575 Million

Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer

PR Newswire

3 months ago

Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer

Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024

PR Newswire

3 months ago

Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024

From Opposite Ends of the Earth, the Same Story: Women Push for Positive Change

ACCESSWIRE

3 months ago

From Opposite Ends of the Earth, the Same Story: Women Push for Positive Change

Do Options Traders Know Something About Viatris (VTRS) Stock We Don't?

Zacks

3 months ago

Do Options Traders Know Something About Viatris (VTRS) Stock We Don't?

Viatris 2023 Sustainability Report: Advocating for Patients

ACCESSWIRE

3 months ago

Viatris 2023 Sustainability Report: Advocating for Patients

Icon PLC (ICLR) Surges 3.3%: Is This an Indication of Further Gains?

Zacks

3 months ago

Icon PLC (ICLR) Surges 3.3%: Is This an Indication of Further Gains?

MT Newswires

3 months ago

Viatris Says $432 Million Viatris Notes, 208.1 Million Euros of Mylan Notes Tendered

Viatris Announces Expiration and Results of Any and All Cash Tender Offers

PR Newswire

3 months ago

Viatris Announces Expiration and Results of Any and All Cash Tender Offers

MT Newswires

3 months ago

Viatris Prices Cash Tender Offers for Senior Notes

Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers

PR Newswire

3 months ago

Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers

Viatris 2023 Sustainability Report: Breaking Down Systemic Barriers To Access Through Policy Engagement

ACCESSWIRE

3 months ago

Viatris 2023 Sustainability Report: Breaking Down Systemic Barriers To Access Through Policy Engagement

Viatris 2023 Sustainability Report: Continued Innovation for Infectious Disease

ACCESSWIRE

3 months ago

Viatris 2023 Sustainability Report: Continued Innovation for Infectious Disease

MT Newswires

3 months ago

Viatris Launches Cash Tender Offers for Senior Notes

Viatris Announces Cash Tender Offers for Certain Outstanding Notes

PR Newswire

3 months ago

Viatris Announces Cash Tender Offers for Certain Outstanding Notes

Argus Research

3 months ago

Analyst Report: Viatris Inc

Argus Research

3 months ago

Market Update: CRM, HAS, VTRS, TRGP

MT Newswires

4 months ago

Viatris Insider Sold Shares Worth $1,195,075, According to a Recent SEC Filing

ESC 2024: Single-pill hypertension combo delivers positive results

Pharmaceutical Technology

4 months ago

ESC 2024: Single-pill hypertension combo delivers positive results

Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress

PR Newswire

4 months ago

Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress

3 Top Value Stocks to Buy Right Now

Motley Fool

4 months ago

3 Top Value Stocks to Buy Right Now

Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics

Zacks

4 months ago

Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics

Decoding Viatris Inc (VTRS): A Strategic SWOT Insight

GuruFocus.com

4 months ago

Decoding Viatris Inc (VTRS): A Strategic SWOT Insight

Morningstar Research

4 months ago

Analyst Report: Viatris Inc.

Midday stock movers: Warner Bros. sinks, Nvidia, Rivian, Eli Lilly up

TheStreet

4 months ago

Midday stock movers: Warner Bros. sinks, Nvidia, Rivian, Eli Lilly up

Why Viatris Stock Is Jumping Today

Motley Fool

4 months ago

Why Viatris Stock Is Jumping Today

Viatris (VTRS) Q2 Earnings Outpace Estimates, Sales Miss

Zacks

4 months ago

Viatris (VTRS) Q2 Earnings Outpace Estimates, Sales Miss

Viatris (VTRS) Q2 Earnings Surpass Estimates

Zacks

4 months ago

Viatris (VTRS) Q2 Earnings Surpass Estimates

MT Newswires

4 months ago

Viatris' Q2 Adjusted Earnings, Revenue Fall; Lowers 2024 Guidance

Associated Press Finance

4 months ago

Viatris: Q2 Earnings Snapshot

Viatris Reports Second Quarter Financial Results for 2024

PR Newswire

4 months ago

Viatris Reports Second Quarter Financial Results for 2024

Viatris Inc (VTRS) Q2 2024 Earnings Report Preview: What To Expect

GuruFocus.com

4 months ago

Viatris Inc (VTRS) Q2 2024 Earnings Report Preview: What To Expect

Why Is Viatris Inc. (VTRS) the Best Dividend-Paying Stock to Buy Under $15?

Insider Monkey

4 months ago

Why Is Viatris Inc. (VTRS) the Best Dividend-Paying Stock to Buy Under $15?

Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y

Zacks

4 months ago

Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y

Viatris Announces Second Quarter 2024 Dividend

PR Newswire

4 months ago

Viatris Announces Second Quarter 2024 Dividend

Novartis, Viatris face new lawsuit over 'HeLa' cell misuse claims

Reuters

4 months ago

Novartis, Viatris face new lawsuit over 'HeLa' cell misuse claims

Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?

Zacks

4 months ago

Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?

Seeking Clues to Viatris (VTRS) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Zacks

4 months ago

Seeking Clues to Viatris (VTRS) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Earnings Preview: Viatris (VTRS) Q2 Earnings Expected to Decline

Zacks

5 months ago

Earnings Preview: Viatris (VTRS) Q2 Earnings Expected to Decline

Viatris (VTRS) to Report Q2 Earnings: What's in the Cards?

Zacks

5 months ago

Viatris (VTRS) to Report Q2 Earnings: What's in the Cards?

Aspargo Labs Publishes Results on First Oral Spray for Erectile Dysfunction

Exec Edge

5 months ago

Aspargo Labs Publishes Results on First Oral Spray for Erectile Dysfunction

Viatris 2023 Sustainability Report: Empowering Healthcare Workers

ACCESSWIRE

5 months ago

Viatris 2023 Sustainability Report: Empowering Healthcare Workers

3 Surprisingly Underrated Stocks to Buy Right Now

Motley Fool

5 months ago

3 Surprisingly Underrated Stocks to Buy Right Now

Viatris 2023 Sustainability Report: Building Access Through a Global and Flexible Supply Chain

ACCESSWIRE

5 months ago

Viatris 2023 Sustainability Report: Building Access Through a Global and Flexible Supply Chain

Viatris 2023 Sustainability Report: Our Strategy and Model for Sustainable Access to Medicine

ACCESSWIRE

5 months ago

Viatris 2023 Sustainability Report: Our Strategy and Model for Sustainable Access to Medicine

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Zacks

5 months ago

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Viatris closes $3.37bn divestitures with OTC deal

Pharmaceutical Technology

5 months ago

Viatris closes $3.37bn divestitures with OTC deal

MT Newswires

6 months ago

Viatris Divests Over-the-Counter Business to Cooper Consumer Health

Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture

PR Newswire

6 months ago

Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture

MT Newswires

6 months ago

Viatris Says US Department of Justice's Antitrust Division No Longer Considers Mylan Subject of Investigation

U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation

PR Newswire

6 months ago

U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation

Here's Why You May Invest in Theravance (TBPH) Stock Now

Zacks

6 months ago

Here's Why You May Invest in Theravance (TBPH) Stock Now

Viatris Named to TIME’s World’s Most Sustainable Companies 2024 List

ACCESSWIRE

6 months ago

Viatris Named to TIME’s World’s Most Sustainable Companies 2024 List

Viatris Named to TIME's World's Most Sustainable Companies 2024 List

PR Newswire

6 months ago

Viatris Named to TIME's World's Most Sustainable Companies 2024 List

MT Newswires

6 months ago

Regeneron Pharmaceuticals Wins Injunctions Against Biosimilars to Eye Disease Drug Eylea

Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024

PR Newswire

6 months ago

Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024

Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

PR Newswire

6 months ago

Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Share on Social Networks: